ID   SHIP1_RAT               Reviewed;        1190 AA.
AC   P97573;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   02-OCT-2024, entry version 140.
DE   RecName: Full=Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1;
DE            EC=3.1.3.86 {ECO:0000269|PubMed:8910587};
DE   AltName: Full=Inositol polyphosphate-5-phosphatase D;
DE            EC=3.1.3.56 {ECO:0000250|UniProtKB:Q92835};
DE   AltName: Full=Phosphatidylinositol-4,5-bisphosphate 5-phosphatase;
DE            EC=3.1.3.36 {ECO:0000250|UniProtKB:Q92835};
DE   AltName: Full=SH2 domain-containing inositol 5'-phosphatase 1;
DE            Short=SH2 domain-containing inositol phosphatase 1;
DE            Short=SHIP-1;
GN   Name=Inpp5d; Synonyms=Ship, Ship1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, PHOSPHORYLATION, AND
RP   INTERACTION WITH MS4A2; SHC1; GRB2 AND FCER1G.
RX   PubMed=8910587; DOI=10.1074/jbc.271.46.29271;
RA   Osborne M.A., Zenner G., Lubinus M., Zhang X., Songyang Z., Cantley L.C.,
RA   Majerus P., Burn P., Kochan J.P.;
RT   "The inositol 5'-phosphatase SHIP binds to immunoreceptor signaling motifs
RT   and responds to high affinity IgE receptor aggregation.";
RL   J. Biol. Chem. 271:29271-29278(1996).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245; THR-963 AND SER-971, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Phosphatidylinositol (PtdIns) phosphatase that specifically
CC       hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate
CC       (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively
CC       regulating the PI3K (phosphoinositide 3-kinase) pathways
CC       (PubMed:8910587). Also able to hydrolyze the 5-phosphate of
CC       phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P3) and inositol
CC       1,3,4,5-tetrakisphosphate (By similarity). Acts as a negative regulator
CC       of B-cell antigen receptor signaling. Mediates signaling from the FC-
CC       gamma-RIIB receptor (FCGR2B), playing a central role in terminating
CC       signal transduction from activating immune/hematopoietic cell receptor
CC       systems. Acts as a negative regulator of myeloid cell
CC       proliferation/survival and chemotaxis, mast cell degranulation, immune
CC       cells homeostasis, integrin alpha-IIb/beta-3 signaling in platelets and
CC       JNK signaling in B-cells. Regulates proliferation of osteoclast
CC       precursors, macrophage programming, phagocytosis and activation and is
CC       required for endotoxin tolerance. Involved in the control of cell-cell
CC       junctions, CD32a signaling in neutrophils and modulation of EGF-induced
CC       phospholipase C activity. Key regulator of neutrophil migration, by
CC       governing the formation of the leading edge and polarization required
CC       for chemotaxis. Modulates FCGR3/CD16-mediated cytotoxicity in NK cells.
CC       Mediates the activin/TGF-beta-induced apoptosis through its Smad-
CC       dependent expression (By similarity). {ECO:0000250|UniProtKB:Q92835,
CC       ECO:0000269|PubMed:8910587}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-
CC         trisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol-3,4-bisphosphate) + phosphate; Xref=Rhea:RHEA:25528,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:57658,
CC         ChEBI:CHEBI:57836; EC=3.1.3.86;
CC         Evidence={ECO:0000269|PubMed:8910587};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O = 1D-myo-
CC         inositol 1,3,4-trisphosphate + phosphate; Xref=Rhea:RHEA:11392,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:57895,
CC         ChEBI:CHEBI:58414; EC=3.1.3.56;
CC         Evidence={ECO:0000250|UniProtKB:Q92835};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol 4-phosphate) + phosphate; Xref=Rhea:RHEA:22764,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:58178,
CC         ChEBI:CHEBI:58456; EC=3.1.3.36;
CC         Evidence={ECO:0000250|UniProtKB:Q92835};
CC   -!- ACTIVITY REGULATION: Activated upon translocation to the sites of
CC       synthesis of PtdIns(3,4,5)P3 in the membrane. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with tyrosine phosphorylated forms of SHC1
CC       (PubMed:8910587). Interacts with tyrosine phosphorylated form of DOK1
CC       (By similarity). Interacts with tyrosine phosphorylated form of DOK3
CC       (By similarity). Interacts with tyrosine phosphorylated form of
CC       SLAMF1/CD150 (By similarity). Interacts with PTPN11/SHP-2 in response
CC       to IL-3 (By similarity). Interacts with receptor EPOR (By similarity).
CC       Interacts with receptors MS4A2/FCER1B and FCER1G (PubMed:8910587).
CC       Interacts with receptors FCGR2B and FCGR3 (By similarity). Interacts
CC       with receptor FCGR2A, leading to regulate gene expression during the
CC       phagocytic process (By similarity). Interacts with GRB2
CC       (PubMed:8910587). Interacts with PLCG1 (By similarity). Interacts with
CC       tyrosine kinases SRC and TEC (By similarity). Interacts with c-Met/MET
CC       (By similarity). Interacts with MILR1 (tyrosine-phosphorylated) (By
CC       similarity). Can weakly interact (via NPXY motif 2) with DAB2 (via PID
CC       domain); the interaction is impaired by tyrosine phosphorylation of the
CC       NPXY motif (By similarity). Interacts (via SH2 domain) with tyrosine
CC       phosphorylated KLRC1 (via ITIM). {ECO:0000250|UniProtKB:Q92835,
CC       ECO:0000250|UniProtKB:Q9ES52, ECO:0000269|PubMed:8910587}.
CC   -!- INTERACTION:
CC       P97573; Q96RU3: FNBP1; Xeno; NbExp=2; IntAct=EBI-8008869, EBI-1111248;
CC       P97573; Q15642-1: TRIP10; Xeno; NbExp=2; IntAct=EBI-8008869, EBI-16191375;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9ES52}. Cell
CC       membrane {ECO:0000250|UniProtKB:Q9ES52}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q9ES52}. Membrane raft
CC       {ECO:0000250|UniProtKB:Q9ES52}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q9ES52}. Note=Translocates to the plasma
CC       membrane when activated, translocation is probably due to different
CC       mechanisms depending on the stimulus and cell type. Translocates from
CC       the cytoplasm to membrane ruffles in a FCGR3/CD16-dependent manner.
CC       Colocalizes with FC-gamma-RIIB receptor (FCGR2B) or FCGR3/CD16 at
CC       membrane ruffles. Tyrosine phosphorylation may also participate in
CC       membrane localization. {ECO:0000250|UniProtKB:Q9ES52}.
CC   -!- DOMAIN: The SH2 domain interacts with tyrosine phosphorylated forms of
CC       proteins such as SHC1 or PTPN11/SHP-2. It competes with that of GRB2
CC       for binding to phosphorylated SHC1 to inhibit the Ras pathway. It is
CC       also required for tyrosine phosphorylation (By similarity).
CC       {ECO:0000250|UniProtKB:Q9ES52}.
CC   -!- DOMAIN: The NPXY sequence motif found in many tyrosine-phosphorylated
CC       proteins is required for the specific binding of the PID domain.
CC       {ECO:0000250|UniProtKB:Q9ES52}.
CC   -!- PTM: Tyrosine phosphorylated by the members of the SRC family after
CC       exposure to a diverse array of extracellular stimuli such as cytokines,
CC       growth factors, antibodies, chemokines, integrin ligands and hypertonic
CC       and oxidative stress. Phosphorylated upon IgG receptor FCGR2B-binding.
CC       {ECO:0000269|PubMed:8910587}.
CC   -!- SIMILARITY: Belongs to the inositol 1,4,5-trisphosphate 5-phosphatase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U55192; AAB40610.1; -; mRNA.
DR   RefSeq; NP_062184.1; NM_019311.1.
DR   AlphaFoldDB; P97573; -.
DR   SMR; P97573; -.
DR   BioGRID; 248482; 6.
DR   DIP; DIP-42709N; -.
DR   IntAct; P97573; 15.
DR   MINT; P97573; -.
DR   STRING; 10116.ENSRNOP00000040111; -.
DR   iPTMnet; P97573; -.
DR   PhosphoSitePlus; P97573; -.
DR   PaxDb; 10116-ENSRNOP00000040111; -.
DR   GeneID; 54259; -.
DR   KEGG; rno:54259; -.
DR   UCSC; RGD:2914; rat.
DR   AGR; RGD:2914; -.
DR   CTD; 3635; -.
DR   RGD; 2914; Inpp5d.
DR   eggNOG; KOG0565; Eukaryota.
DR   InParanoid; P97573; -.
DR   OrthoDB; 21647at2759; -.
DR   PhylomeDB; P97573; -.
DR   Reactome; R-RNO-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-RNO-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-RNO-202424; Downstream TCR signaling.
DR   Reactome; R-RNO-210990; PECAM1 interactions.
DR   Reactome; R-RNO-912526; Interleukin receptor SHC signaling.
DR   PRO; PR:P97573; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005884; C:actin filament; IDA:RGD.
DR   GO; GO:0030863; C:cortical cytoskeleton; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0052659; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052658; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0030487; F:inositol-4,5-bisphosphate 5-phosphatase activity; IDA:RGD.
DR   GO; GO:0004445; F:inositol-polyphosphate 5-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0034485; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004439; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0008340; P:determination of adult lifespan; ISO:RGD.
DR   GO; GO:0016064; P:immunoglobulin mediated immune response; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0050869; P:negative regulation of B cell activation; ISO:RGD.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; ISO:RGD.
DR   GO; GO:0045779; P:negative regulation of bone resorption; ISO:RGD.
DR   GO; GO:0030853; P:negative regulation of granulocyte differentiation; ISO:RGD.
DR   GO; GO:0050777; P:negative regulation of immune response; ISO:RGD.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0045656; P:negative regulation of monocyte differentiation; ISO:RGD.
DR   GO; GO:0045659; P:negative regulation of neutrophil differentiation; ISO:RGD.
DR   GO; GO:0045671; P:negative regulation of osteoclast differentiation; ISO:RGD.
DR   GO; GO:0009968; P:negative regulation of signal transduction; ISO:RGD.
DR   GO; GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:InterPro.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0045579; P:positive regulation of B cell differentiation; ISO:RGD.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0045621; P:positive regulation of lymphocyte differentiation; ISO:RGD.
DR   GO; GO:0050776; P:regulation of immune response; IBA:GO_Central.
DR   CDD; cd09100; INPP5c_SHIP1-INPP5D; 1.
DR   CDD; cd10343; SH2_SHIP; 1.
DR   Gene3D; 3.60.10.10; Endonuclease/exonuclease/phosphatase; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   InterPro; IPR036691; Endo/exonu/phosph_ase_sf.
DR   InterPro; IPR000300; IPPc.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   PANTHER; PTHR46051:SF3; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE 5-PHOSPHATASE 1; 1.
DR   PANTHER; PTHR46051; SH2 DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF22669; Exo_endo_phos2; 1.
DR   Pfam; PF00017; SH2; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00128; IPPc; 1.
DR   SMART; SM00252; SH2; 1.
DR   SUPFAM; SSF56219; DNase I-like; 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Cell membrane; Cytoplasm; Cytoskeleton; Hydrolase; Immunity;
KW   Lipid metabolism; Membrane; Phosphoprotein; Reference proteome; Repeat;
KW   SH2 domain; SH3-binding.
FT   CHAIN           1..1190
FT                   /note="Phosphatidylinositol 3,4,5-trisphosphate 5-
FT                   phosphatase 1"
FT                   /id="PRO_0000302868"
FT   DOMAIN          8..104
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   REGION          110..130
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          946..1190
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1014..1028
FT                   /note="Interaction with DAB2"
FT                   /evidence="ECO:0000250"
FT   MOTIF           126..131
FT                   /note="SH3-binding 1"
FT   MOTIF           914..917
FT                   /note="NPXY motif 1"
FT   MOTIF           969..974
FT                   /note="SH3-binding 2"
FT   MOTIF           1017..1020
FT                   /note="NPXY motif 2"
FT   MOTIF           1038..1049
FT                   /note="SH3-binding 3"
FT   COMPBIAS        972..986
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1087..1101
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1160..1183
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         245
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         917
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92835"
FT   MOD_RES         934
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES52"
FT   MOD_RES         944
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES52"
FT   MOD_RES         963
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         966
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES52"
FT   MOD_RES         971
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1020
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES52"
SQ   SEQUENCE   1190 AA;  133593 MW;  85DD4F2190F98700 CRC64;
     MPAMVPGWNH GNITRSKAEE LLSRAGKDGS FLVRASESIP RAYALCVLFR NCVYTYRILP
     NEDDKFTVQA SEGVPMRFFT KLDQLIEFYK KENMGLVTHL QFPVPLEEED AIDEPEEDTE
     SVMSPPELPP RNIPVSGGPC EAKDLPLPTE NPRAPEVTRL SLSETLFQRL QSMDTSGLPE
     EHLKAIQDYL STQLMLDSDF LKTGSSNLPH LKKLTSLLCK ELHGEVIRTL PSLESLQRLF
     DQQLSPGLRP RPQVPGEANP ITMVAKLSQL TSLLSSIEDK VKALLHEGSE STNRRSLIPP
     VTFEVKSESL GIPQKMHLKV DVESGKLIIK KSRDGSEDKF YSHKKILQLI KSQKFLNKLV
     ILVETEKEKI LRKEYVFSDS KKREGFCQLL QQMKNKHSEQ SEPDMITIFI GTWNMGNAPP
     PKKITSWFLS KGQGKTRDDS ADYIPHDIYV IGTQEDPLGE KEWLEILRHS LQEVTSMTFK
     TVAIHTLWNI RIVVLAKPEH ENRISHICTD NVKTGIANTL GNKGAVGVSF MFNGTSLGFV
     NSHLTSGSEK KLRRNQNYMN ILRFLALGDK KLSPFNITHR FTHLFWLGDL NYRVELPTWE
     AEAIIQKIKQ QQYSDLLAHD QLLLERKEQE VFLHFEEEEI TFAPTYRFER LTRDKYAYTK
     QKATGMKYNL PSWCDRVLWK SYPLVHVVCQ SYGSTSDIMT SDHSPVFATF EAGVTSQFVS
     KNGPGAVDSQ GQIEFLACYA TLKTKSQTKF YLELHSSCLE SFVKSQEGEN EEGDEGELVV
     RFGETLPKLK PIISDPEYLL DQHILISIKS SDSDESYGEG CIALRLETTE SQLPIYTPLT
     HHGEMTGHFR GEIKLQTSEG KMREKLYDFV KTERDESSGM KCLKNLTSHD PMRQWEPAGR
     VPACGISSLN EIINPNYIGM GPFGQPLHGK STLSPDQQLT AWSYDQLPKD SSLGPGRGEG
     PPTPPSQPPL SPKKFSSSTA NRGSCPRVQE TRPGDLGKVE ALPQEDLPLT KPEMFENPLY
     GSVSPFPKLV PRKEQESPKM MRKEPPPCPD PGVSSPSIML PKAQEVENVK GTSKQAPVPV
     FGPTPRIRSF TCSSSAEGRM PSGDKSQGKP KAPASSQAPV PVKRPVKPSR SEMSQQTTPI
     PAPRPPLPVK SPAVLQLQHS KGRDYRDNTE LPHHGKHRQE ESLLGRTAMQ
//
